vs

Side-by-side financial comparison of Torrid Holdings Inc. (CURV) and VERACYTE, INC. (VCYT). Click either name above to swap in a different company.

Torrid Holdings Inc. is the larger business by last-quarter revenue ($235.2M vs $139.1M, roughly 1.7× VERACYTE, INC.). VERACYTE, INC. runs the higher net margin — 20.6% vs -2.7%, a 23.4% gap on every dollar of revenue. On growth, VERACYTE, INC. posted the faster year-over-year revenue change (21.5% vs -10.8%). Over the past eight quarters, VERACYTE, INC.'s revenue compounded faster (10.2% CAGR vs -10.5%).

Torrid Holdings Inc. is an American women's retail chain formerly owned by Hot Topic. While it is still owned by Sycamore Partners, owners of Hot Topic, in 2015, the company branched off to become Torrid, LLC. The store offers plus-size clothing and accessories for women size 10-30. Torrid began operations in April 2001. The first location opened in the Brea Mall in Brea, California. As of 2024, Torrid has over 650 stores in operation across all states in the United States and some regions of...

Veracyte Inc. is a leading molecular diagnostics company that develops and commercializes proprietary genomic testing solutions for early, accurate detection of cancer and other complex diseases. Its offerings help healthcare providers make better clinical decisions to improve patient outcomes, with core operations in the U.S. and expanding global market presence across key clinical segments.

CURV vs VCYT — Head-to-Head

Bigger by revenue
CURV
CURV
1.7× larger
CURV
$235.2M
$139.1M
VCYT
Growing faster (revenue YoY)
VCYT
VCYT
+32.3% gap
VCYT
21.5%
-10.8%
CURV
Higher net margin
VCYT
VCYT
23.4% more per $
VCYT
20.6%
-2.7%
CURV
Faster 2-yr revenue CAGR
VCYT
VCYT
Annualised
VCYT
10.2%
-10.5%
CURV

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CURV
CURV
VCYT
VCYT
Revenue
$235.2M
$139.1M
Net Profit
$-6.4M
$28.7M
Gross Margin
34.9%
72.7%
Operating Margin
0.1%
16.3%
Net Margin
-2.7%
20.6%
Revenue YoY
-10.8%
21.5%
Net Profit YoY
-438.2%
EPS (diluted)
$-0.06
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURV
CURV
VCYT
VCYT
Q1 26
$139.1M
Q4 25
$235.2M
$140.6M
Q3 25
$262.8M
$131.9M
Q2 25
$266.0M
$130.2M
Q1 25
$275.6M
$114.5M
Q4 24
$263.8M
$118.6M
Q3 24
$284.6M
$115.9M
Q2 24
$279.8M
$114.4M
Net Profit
CURV
CURV
VCYT
VCYT
Q1 26
$28.7M
Q4 25
$-6.4M
$41.1M
Q3 25
$1.6M
$19.1M
Q2 25
$5.9M
$-980.0K
Q1 25
$-3.0M
$7.0M
Q4 24
$-1.2M
$5.1M
Q3 24
$8.3M
$15.2M
Q2 24
$12.2M
$5.7M
Gross Margin
CURV
CURV
VCYT
VCYT
Q1 26
72.7%
Q4 25
34.9%
72.5%
Q3 25
35.6%
69.2%
Q2 25
38.1%
69.0%
Q1 25
33.6%
69.5%
Q4 24
36.1%
66.4%
Q3 24
38.7%
68.2%
Q2 24
41.3%
68.1%
Operating Margin
CURV
CURV
VCYT
VCYT
Q1 26
16.3%
Q4 25
0.1%
26.4%
Q3 25
3.9%
17.4%
Q2 25
6.0%
-4.0%
Q1 25
1.3%
2.5%
Q4 24
2.7%
3.5%
Q3 24
7.2%
10.4%
Q2 24
9.3%
4.0%
Net Margin
CURV
CURV
VCYT
VCYT
Q1 26
20.6%
Q4 25
-2.7%
29.3%
Q3 25
0.6%
14.5%
Q2 25
2.2%
-0.8%
Q1 25
-1.1%
6.2%
Q4 24
-0.5%
4.3%
Q3 24
2.9%
13.1%
Q2 24
4.4%
5.0%
EPS (diluted)
CURV
CURV
VCYT
VCYT
Q1 26
$0.35
Q4 25
$-0.06
$0.50
Q3 25
$0.02
$0.24
Q2 25
$0.06
$-0.01
Q1 25
$-0.04
$0.09
Q4 24
$-0.01
$0.07
Q3 24
$0.08
$0.19
Q2 24
$0.12
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURV
CURV
VCYT
VCYT
Cash + ST InvestmentsLiquidity on hand
$17.2M
$439.1M
Total DebtLower is stronger
$276.4M
Stockholders' EquityBook value
$-206.5M
$1.3B
Total Assets
$402.9M
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURV
CURV
VCYT
VCYT
Q1 26
$439.1M
Q4 25
$17.2M
$362.6M
Q3 25
$21.5M
$315.6M
Q2 25
$23.7M
$219.5M
Q1 25
$48.5M
$186.1M
Q4 24
$44.0M
$239.1M
Q3 24
$53.9M
$274.1M
Q2 24
$20.5M
$235.9M
Total Debt
CURV
CURV
VCYT
VCYT
Q1 26
Q4 25
$276.4M
Q3 25
$280.5M
Q2 25
$284.5M
Q1 25
$288.6M
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CURV
CURV
VCYT
VCYT
Q1 26
$1.3B
Q4 25
$-206.5M
$1.3B
Q3 25
$-201.1M
$1.3B
Q2 25
$-183.8M
$1.2B
Q1 25
$-191.1M
$1.2B
Q4 24
$-189.3M
$1.2B
Q3 24
$-188.9M
$1.2B
Q2 24
$-198.6M
$1.1B
Total Assets
CURV
CURV
VCYT
VCYT
Q1 26
$1.4B
Q4 25
$402.9M
$1.4B
Q3 25
$414.5M
$1.4B
Q2 25
$451.4M
$1.3B
Q1 25
$488.4M
$1.3B
Q4 24
$493.0M
$1.3B
Q3 24
$487.5M
$1.3B
Q2 24
$479.7M
$1.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURV
CURV
VCYT
VCYT
Operating Cash FlowLast quarter
$-4.9M
$35.2M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
1.23×
TTM Free Cash FlowTrailing 4 quarters
$-2.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURV
CURV
VCYT
VCYT
Q1 26
$35.2M
Q4 25
$-4.9M
$52.6M
Q3 25
$15.7M
$44.8M
Q2 25
$-18.0M
$33.6M
Q1 25
$12.0M
$5.4M
Q4 24
$-3.1M
$24.5M
Q3 24
$40.8M
$30.0M
Q2 24
$27.6M
$29.6M
Free Cash Flow
CURV
CURV
VCYT
VCYT
Q1 26
Q4 25
$-6.6M
$48.8M
Q3 25
$14.6M
$42.0M
Q2 25
$-20.6M
$32.3M
Q1 25
$10.2M
$3.5M
Q4 24
$-5.5M
$20.4M
Q3 24
$37.7M
$27.7M
Q2 24
$20.6M
$26.8M
FCF Margin
CURV
CURV
VCYT
VCYT
Q1 26
Q4 25
-2.8%
34.7%
Q3 25
5.6%
31.8%
Q2 25
-7.7%
24.8%
Q1 25
3.7%
3.1%
Q4 24
-2.1%
17.2%
Q3 24
13.2%
23.9%
Q2 24
7.4%
23.4%
Capex Intensity
CURV
CURV
VCYT
VCYT
Q1 26
Q4 25
0.7%
2.7%
Q3 25
0.4%
2.1%
Q2 25
1.0%
1.0%
Q1 25
0.6%
1.6%
Q4 24
0.9%
3.5%
Q3 24
1.1%
1.9%
Q2 24
2.5%
2.4%
Cash Conversion
CURV
CURV
VCYT
VCYT
Q1 26
1.23×
Q4 25
1.28×
Q3 25
10.05×
2.34×
Q2 25
-3.03×
Q1 25
0.76×
Q4 24
4.80×
Q3 24
4.90×
1.98×
Q2 24
2.27×
5.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CURV
CURV

Apparel$213.6M91%
Non Apparel$12.3M5%
Other$9.2M4%
Loyalty Program$1.1M0%

VCYT
VCYT

Testing revenue$135.1M97%
Product revenue$3.7M3%
Biopharmaceutical and other revenue$301.0K0%

Related Comparisons